Floatz logo

Abbv-932

Bipolar I Disorder

AbbViePhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
81/ 100

Competitive context

33 Active assets in the Bipolar I Disorder cohort.

Asset / SponsorPhaseRating
Lurasidone
Massachusetts General Hospital
Phase 4BBB
LITHIUM, ELEMENTAL
Alzamend Neuro, Inc.
Phase 4BBB
Cipralex
Massachusetts General Hospital
Phase 4BBB
Olanzapine
Alkermes, Inc.
Phase 4BBB
Asenapine
Organon and Co
Phase 3BBB

View all 50 →

Same molecule, other indications

Abbv-932 is also rated in:

bipolar II disorderDormant
B
Indicative ·
57 / 100
View asset →
Healthy VolunteersDormant
CC
Indicative ·
44 / 100
View asset →
bipolar disorderDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →